Skip to main content

Find Clinical Trials

Home
Conditions
Urethral Neoplasms

Clinical trial condition

Urethral Neoplasms

Explore clinical trials studying Urethral Neoplasms. Study availability and eligibility vary by location and protocol.

82 public trials 7 recruiting studies

Refine in advanced search Browse all conditions

Urethral Neoplasms trial results

Completed

Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants

NCT00900276

Conditions: Adenocarcinoma, Bladder Cancer, Carcinoma, +21 more
Locations: Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States

View Trial Details

Completed

Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium

NCT01090466

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Leeds Cancer Centre at St. James's University Hospital Leeds, England, United Kingdom

View Trial Details

Completed

Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal Cancer

NCT00003704

Conditions: Adnexal Diseases, Anus Diseases, Anus Neoplasms, +56 more
Locations: CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States

CCOP - Carle Cancer Center Urbana, Illinois, United States

CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States

CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States

View all 18 locations

View Trial Details

Completed

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

NCT00083213

Conditions: Adenocarcinoma, Adnexal Diseases, Burkitt Lymphoma, +81 more
Locations: Memorial Sloan - Kettering Cancer Center New York, United States

View Trial Details

Completed

Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's Lymphoma

NCT00082823

Conditions: Adenocarcinoma, Adnexal Diseases, Burkitt Lymphoma, +81 more
Locations: Memorial Sloan - Kettering Cancer Center New York, United States

Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium

NCT00397488

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium

NCT00082719

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Videoscopic Versus Open Inguinal Lymphadenectomy for Cancer

NCT01526486

Conditions: Adenocarcinoma, Anal Cancer, Anus Diseases, +67 more
Locations: Emory University Hospital-Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Completed

VEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the Urothelium

NCT00407485

Conditions: Adenocarcinoma of the Bladder, Distal Urethral Cancer, Female Urogenital Diseases, +23 more
Locations: City of Hope Duarte, California, United States

View Trial Details

Completed

Pazopanib in Treating Patients With Metastatic Urothelial Cancer

NCT00471536

Conditions: Distal Urethral Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +18 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

Johns Hopkins University Baltimore, Maryland, United States

Wayne State University Detroit, Michigan, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details